Deborah S Sutherland

Title: Innovations in Pharmaceutical Methods by Deborah S. Sutherland

Introduction

Deborah S. Sutherland is a notable inventor based in Richmond, VA (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative methods involving fused imidazoheterocyclic compounds. With a total of 5 patents to her name, her work has implications for treating various conditions in living organisms.

Latest Patents

Her latest patents focus on pharmaceutical methods using fused imidazoheterocyclic compounds. These compounds are characterized by specific formulas where the A ring is pyridine in any of its four positions. The B component can be carbonyl, thioxomethyl, or hydroxymethylene, while Z can be hydrogen, halogen, loweralkyl, hydroxy, loweralkoxy, diloweralkylamino, or nitro. Additionally, Ar can be phenyl, pyrido, thienyl, or furanyl. The W component allows for a wide combination of groups with B, including acids, esters, alcohols, amides, and ketones. The compounds exhibit CNS activity and are utilized in methods for treating living animal bodies as muscle relaxants, anticonvulsants, and antianxiety agents.

Career Highlights

Deborah S. Sutherland is currently associated with A. H. Robins Company, Incorporated, where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the understanding and application of imidazoheterocyclic compounds in medical treatments.

Collaborations

One of her notable collaborators is Bruce E. Tomczuk, with whom she has worked closely on various projects related to her patents.

Conclusion

Deborah S. Sutherland's contributions to pharmaceutical innovations highlight her expertise and dedication to improving medical treatments. Her work with fused imidazoheterocyclic compounds represents a significant advancement in the field, showcasing her role as a leading inventor.